Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.

Lohmann S, Brix T, Varghese J, Warneke N, Schwake M, Suero Molina E, Holling M, Stummer W, Schipmann S.

J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186. [Epub ahead of print]

PMID:
32197255
2.

Diagnostic accuracy of different clinical screening criteria for blunt cerebrovascular injuries compared to liberal state of the art computed tomography angiography in major trauma.

Müther M, Sporns PB, Hanning U, Düsing H, Hartensuer R, Raschke M, Schwake M, Stummer W, Glasgow S.

J Trauma Acute Care Surg. 2020 Mar 18. doi: 10.1097/TA.0000000000002682. [Epub ahead of print]

PMID:
32195997
3.

Commentary: Perilesional Resection of Glioblastoma is Independently Associated With Improved Outcomes.

Müther M, Stummer W.

Neurosurgery. 2020 Feb 28. pii: nyaa045. doi: 10.1093/neuros/nyaa045. [Epub ahead of print] No abstract available.

PMID:
32109287
4.

TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma.

Zinnhardt B, Müther M, Roll W, Backhaus P, Jeibmann A, Foray C, Barca C, Döring C, Tavitian B, Dollé F, Weckesser M, Winkeler A, Hermann S, Wagner S, Wiendl H, Stummer W, Jacobs AH, Schäfers M, Grauer OM.

Neuro Oncol. 2020 Feb 12. pii: noaa023. doi: 10.1093/neuonc/noaa023. [Epub ahead of print]

PMID:
32047908
5.

Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.

Suero Molina E, Stögbauer L, Jeibmann A, Warneke N, Stummer W.

Acta Neurochir (Wien). 2020 Apr;162(4):785-793. doi: 10.1007/s00701-020-04227-7. Epub 2020 Feb 7.

6.

Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.

Schipmann S, Müther M, Stögbauer L, Zimmer S, Brokinkel B, Holling M, Grauer O, Suero Molina E, Warneke N, Stummer W.

J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443. [Epub ahead of print]

PMID:
31978877
7.

Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system.

Backhaus P, Roll W, Beuker C, Zinnhardt B, Seifert R, Wenning C, Eisenblätter M, Thomas C, Schmidt-Pogoda A, Strunk D, Wagner S, Faust A, Tüttelmann F, Röpke A, Jacobs AH, Stummer W, Wiendl H, Meuth SG, Schäfers M, Grauer O, Minnerup J.

Eur J Nucl Med Mol Imaging. 2020 Jan 20. doi: 10.1007/s00259-019-04662-4. [Epub ahead of print]

PMID:
31960097
8.

The Use of 5-Aminolevulinic Acid in Low-Grade Glioma Resection: A Systematic Review.

Almekkawi AK, El Ahmadieh TY, Wu EM, Abi-Aad KR, Aoun SG, Plitt AR, El Tecle NE, Patel T, Stummer W, Bendok BR.

Oper Neurosurg (Hagerstown). 2019 Dec 12. pii: opz336. doi: 10.1093/ons/opz336. [Epub ahead of print]

PMID:
31828346
9.

Review of clinical trials in intraoperative molecular imaging during cancer surgery.

Lee JYK, Cho SS, Stummer W, Tanyi JL, Vahrmeijer AL, Rosenthal E, Smith B, Henderson E, Roberts DW, Lee A, Hadjipanayis CG, Bruce JN, Newman JG, Singhal S.

J Biomed Opt. 2019 Dec;24(12):1-8. doi: 10.1117/1.JBO.24.12.120901.

10.

The rise of quality indicators in neurosurgery: 30-day unplanned reoperation rate evaluated in 3760 patients-a single-center experience.

Suero Molina E, Schildmacher C, Doods J, Freistühler M, Hellwig SJ, Stummer W, Schipmann S.

Acta Neurochir (Wien). 2020 Jan;162(1):147-156. doi: 10.1007/s00701-019-04146-2. Epub 2019 Dec 4.

PMID:
31802277
11.

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.

Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stücklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P.

Lancet Oncol. 2019 Dec;20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2. Review.

PMID:
31797797
12.

Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas.

Peetz-Dienhart S, Spille DC, Sporns PB, Adeli A, Bunk EC, Wagner A, Paulus W, Stummer W, Hess K, Brokinkel B.

Neurosurgery. 2020 Mar 1;86(3):E362-E365. doi: 10.1093/neuros/nyz474. No abstract available.

PMID:
31792502
13.

Ependymal fluorescence in fluorescence-guided resection of malignant glioma: a systematic review.

Müther M, Stummer W.

Acta Neurochir (Wien). 2020 Feb;162(2):365-372. doi: 10.1007/s00701-019-04144-4. Epub 2019 Nov 21. Review.

PMID:
31754847
14.

High-Intensity Physical Exercise in a Glioblastoma Patient under Multimodal Treatment.

Troschel FM, Brandt R, Wiewrodt R, Stummer W, Wiewrodt D.

Med Sci Sports Exerc. 2019 Dec;51(12):2429-2433. doi: 10.1249/MSS.0000000000002067.

PMID:
31730561
15.

Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.

Herich S, Schneider-Hohendorf T, Rohlmann A, Khaleghi Ghadiri M, Schulte-Mecklenbeck A, Zondler L, Janoschka C, Ostkamp P, Richter J, Breuer J, Dimitrov S, Rammensee HG, Grauer OM, Klotz L, Gross CC, Stummer W, Missler M, Zarbock A, Vestweber D, Wiendl H, Schwab N.

Brain. 2019 Nov 1;142(11):3411-3427. doi: 10.1093/brain/awz301.

PMID:
31563951
16.

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.

Weller J, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Hau P, Krex D, Grauer O, Goldbrunner R, Bähr O, Uhl M, Seidel C, Tabatabai G, Brehmer S, Bullinger L, Galldiks N, Schaub C, Kebir S, Stummer W, Simon M, Fimmers R, Coch C, Glas M, Herrlinger U, Schäfer N.

Lancet Oncol. 2019 Oct;20(10):1444-1453. doi: 10.1016/S1470-2045(19)30502-9. Epub 2019 Sep 2.

PMID:
31488360
17.

Markers for Identifying and Targeting Glioblastoma Cells during Surgery.

Schipmann S, Schwake M, Suero Molina E, Stummer W.

J Neurol Surg A Cent Eur Neurosurg. 2019 Nov;80(6):475-487. doi: 10.1055/s-0039-1692976. Epub 2019 Aug 29. Review.

PMID:
31466109
18.

Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.

Schwake M, Kaneko S, Suero Molina E, Müther M, Schipmann S, Köchling M, Brentrup A, Stummer W.

Acta Neurochir (Wien). 2019 Oct;161(10):2099-2105. doi: 10.1007/s00701-019-04039-4. Epub 2019 Aug 21.

PMID:
31435824
19.

Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility.

Stummer W, Koch R, Valle RD, Roberts DW, Sanai N, Kalkanis S, Hadjipanayis CG, Suero Molina E.

Acta Neurochir (Wien). 2019 Oct;161(10):2083-2098. doi: 10.1007/s00701-019-04007-y. Epub 2019 Jul 30. Review.

20.

Supramarginal resection of glioblastoma: 5-ALA fluorescence, combined intraoperative strategies and correlation with survival.

Certo F, Stummer W, Farah JO, Freyschlag C, Visocchi M, Morrone A, Altieri R, Toccaceli G, Peschillo S, Thomè C, Jenkinson M, Barbagallo G.

J Neurosurg Sci. 2019 Dec;63(6):625-632. doi: 10.23736/S0390-5616.19.04787-8. Epub 2019 Jul 29.

PMID:
31355623
21.

5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.

Müther M, Koch R, Weckesser M, Sporns P, Schwindt W, Stummer W.

Neurosurgery. 2019 Dec 1;85(6):E1020-E1029. doi: 10.1093/neuros/nyz199.

22.

Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology?

Timme M, Thomas C, Spille DC, Stummer W, Ebel H, Ewelt C, Hans FJ, Schick U, Puchner M, Wildförster U, Bruns B, Trost HA, Holling M, Grauer O, Hess K, Brokinkel B.

Neurosurg Rev. 2019 Jun 3. doi: 10.1007/s10143-019-01125-0. [Epub ahead of print]

PMID:
31161444
23.

Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas.

Streckert EMS, Hess K, Sporns PB, Adeli A, Brokinkel C, Kriz J, Holling M, Eich HT, Paulus W, Spille DC, van Eck ATCJ, Raleigh DR, McDermott MW, Stummer W, Brokinkel B.

Acta Neurochir (Wien). 2019 Aug;161(8):1647-1656. doi: 10.1007/s00701-019-03956-8. Epub 2019 May 31.

PMID:
31147831
24.

Optimizing 5-ALA Induced Fluorescence Visualization: Comment Regarding Recent Article on Fluorescence-Based Real-Time Kinetics Protoporphyrin-IX Measurements Article in Neurosurgery.

Suero Molina E, Kaneko S, Stummer W.

World Neurosurg. 2019 Aug;128:391-392. doi: 10.1016/j.wneu.2019.05.161. Epub 2019 May 24. No abstract available.

PMID:
31132500
25.

Heterotopic Neuroglial Tissue in Sphenoid Ridge.

Bruns AK, Jeibmann A, Brokinkel B, Holling M, Stummer W, Ewelt C.

World Neurosurg. 2019 Feb;122:671-673. doi: 10.1016/j.wneu.2018.10.101. Epub 2018 Oct 25.

PMID:
31108067
26.

Prediction of High-Grade Histology and Recurrence in Meningiomas Using Routine Preoperative Magnetic Resonance Imaging: A Systematic Review.

Spille DC, Sporns PB, Heß K, Stummer W, Brokinkel B.

World Neurosurg. 2019 Aug;128:174-181. doi: 10.1016/j.wneu.2019.05.017. Epub 2019 May 10.

PMID:
31082555
27.

Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas.

Kaneko S, Suero Molina E, Ewelt C, Warneke N, Stummer W.

Neurosurgery. 2019 Oct 1;85(4):E739-E746. doi: 10.1093/neuros/nyz129.

PMID:
31058995
28.

Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note.

Suero Molina E, Ewelt C, Warneke N, Schwake M, Müther M, Schipmann S, Stummer W.

J Neurosurg. 2019 Apr 26:1-7. doi: 10.3171/2018.12.JNS182422. [Epub ahead of print]

PMID:
31026838
29.

Establishing risk-adjusted quality indicators in surgery using administrative data-an example from neurosurgery.

Schipmann S, Varghese J, Brix T, Schwake M, Keurhorst D, Lohmann S, Suero Molina E, Mauer UM, Dugas M, Warneke N, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1057-1065. doi: 10.1007/s00701-018-03792-2. Epub 2019 Apr 26.

PMID:
31025177
30.

Clinical Vasospasm After an Extended Endoscopic Endonasal Approach for Recurrent Pituitary Adenoma: Illustrative Case and Systematic Review of the Literature.

Suero Molina E, Di Somma A, Stummer W, Briganti F, Cavallo LM.

World Neurosurg. 2019 Aug;128:29-36. doi: 10.1016/j.wneu.2019.04.046. Epub 2019 Apr 16.

PMID:
31003025
31.

Effect of Postoperative Radiotherapy for Brain Metastases: An Analysis.

Oertel M, Baehr A, Habibeh O, Haverkamp U, Stummer W, Eich HT, Trog D.

Oncol Res Treat. 2019;42(5):256-262. doi: 10.1159/000499323. Epub 2019 Apr 17.

PMID:
30995671
32.

5-ALA fluorescence-guided surgery in pediatric brain tumors-a systematic review.

Schwake M, Schipmann S, Müther M, Köchling M, Brentrup A, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1099-1108. doi: 10.1007/s00701-019-03898-1. Epub 2019 Apr 13. Review.

PMID:
30989383
33.

Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.

Reulen HJ, Suero Molina E, Zeidler R, Gildehaus FJ, Böning G, Gosewisch A, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1109-1124. doi: 10.1007/s00701-019-03882-9. Epub 2019 Apr 12. Review.

PMID:
30980242
34.

Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.

Stögbauer L, Stummer W, Senner V, Brokinkel B.

Neurosurg Rev. 2019 Feb 20. doi: 10.1007/s10143-019-01087-3. [Epub ahead of print] Review.

PMID:
30788677
35.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
36.

5-ALA fluorescence-guided surgery of CNS tumors.

Hadjipanayis CG, Stummer W, Sheehan JP.

J Neurooncol. 2019 Feb;141(3):477-478. doi: 10.1007/s11060-019-03109-y. No abstract available.

PMID:
30671710
37.

5-ALA and FDA approval for glioma surgery.

Hadjipanayis CG, Stummer W.

J Neurooncol. 2019 Feb;141(3):479-486. doi: 10.1007/s11060-019-03098-y. Epub 2019 Jan 14. Review.

38.

Adverse events in brain tumor surgery: incidence, type, and impact on current quality metrics.

Schipmann S, Brix T, Varghese J, Warneke N, Schwake M, Brokinkel B, Ewelt C, Dugas M, Stummer W.

Acta Neurochir (Wien). 2019 Feb;161(2):287-306. doi: 10.1007/s00701-018-03790-4. Epub 2019 Jan 11.

PMID:
30635727
39.

Light can treat inoperable brain tumours.

Stepp H, Stummer W.

Nature. 2019 Jan;565(7738):161. doi: 10.1038/d41586-019-00020-4. No abstract available.

PMID:
30626953
40.

Second-look strokectomy of cerebral infarction areas in patients with severe herniation.

Schwake M, Schipmann S, Müther M, Stögbauer L, Hanning U, Sporns PB, Ewelt C, Dziewas R, Minnerup J, Holling M, Stummer W.

J Neurosurg. 2019 Jan 4;132(1):1-9. doi: 10.3171/2018.8.JNS18692.

PMID:
30611135
41.

Established and emerging uses of 5-ALA in the brain: an overview.

Díez Valle R, Hadjipanayis CG, Stummer W.

J Neurooncol. 2019 Feb;141(3):487-494. doi: 10.1007/s11060-018-03087-7. Epub 2019 Jan 3. Review.

PMID:
30607705
42.

Cell injury and receptor expression in the epileptic human amygdala.

Jafarian M, Modarres Mousavi SM, Alipour F, Aligholi H, Noorbakhsh F, Ghadipasha M, Gharehdaghi J, Kellinghaus C, Kovac S, Khaleghi Ghadiri M, Meuth SG, Speckmann EJ, Stummer W, Gorji A.

Neurobiol Dis. 2019 Apr;124:416-427. doi: 10.1016/j.nbd.2018.12.017. Epub 2018 Dec 24.

PMID:
30590180
43.

Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging.

Adeli A, Hess K, Mawrin C, Streckert EMS, Stummer W, Paulus W, Kemmling A, Holling M, Heindel W, Schmidt R, Spille DC, Sporns PB, Brokinkel B.

Oncotarget. 2018 Nov 13;9(89):35974-35982. doi: 10.18632/oncotarget.26313. eCollection 2018 Nov 13.

44.

Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients.

Grauer O, Jaber M, Hess K, Weckesser M, Schwindt W, Maring S, Wölfer J, Stummer W.

J Neurooncol. 2019 Jan;141(1):83-94. doi: 10.1007/s11060-018-03005-x. Epub 2018 Dec 1.

45.

Surgical Adjuncts to Increase the Extent of Resection: Intraoperative MRI, Fluorescence, and Raman Histology.

Hollon T, Stummer W, Orringer D, Suero Molina E.

Neurosurg Clin N Am. 2019 Jan;30(1):65-74. doi: 10.1016/j.nec.2018.08.012. Review.

PMID:
30470406
46.

Local Tumor Control and Clinical Symptoms After Gamma Knife Radiosurgery for Residual and Recurrent Vestibular Schwannomas.

Suero Molina E, van Eck ATCJ, Sauerland C, Schipmann S, Horstmann G, Stummer W, Brokinkel B.

World Neurosurg. 2019 Feb;122:e1240-e1246. doi: 10.1016/j.wneu.2018.11.022. Epub 2018 Nov 14.

PMID:
30447443
47.

Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas.

Hendricks BK, Sanai N, Stummer W.

J Neurooncol. 2019 Jan;141(1):13-18. doi: 10.1007/s11060-018-03026-6. Epub 2018 Oct 26. Review.

PMID:
30367383
48.

Complementary Molecular and Elemental Mass-Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery.

Kröger S, Niehoff AC, Jeibmann A, Sperling M, Paulus W, Stummer W, Karst U.

Anal Chem. 2018 Oct 16;90(20):12253-12260. doi: 10.1021/acs.analchem.8b03516. Epub 2018 Oct 2.

PMID:
30215510
49.

Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients.

Rapp M, Schipmann S, Hoffmann K, Wiewrodt R, Steiger HJ, Kamp M, Stummer W, Wiewrodt D, Sabel M.

Oncotarget. 2018 Aug 3;9(60):31650-31663. doi: 10.18632/oncotarget.25833. eCollection 2018 Aug 3.

50.

Spinal meningiomas - Risks and potential of an increasing age at the time of surgery.

Schwake M, Adeli A, Sporns P, Ewelt C, Schmitz T, Sicking J, Hess K, Cäcilia Spille D, Paulus W, Stummer W, Brokinkel B.

J Clin Neurosci. 2018 Nov;57:86-92. doi: 10.1016/j.jocn.2018.08.030. Epub 2018 Aug 23.

PMID:
30145083

Supplemental Content

Loading ...
Support Center